2012.06.13. Innovimmune awarded NIH NIAID SBIR $0.6 Million grant for the development of its oral NCE INV-88 Macrophage Migration Inhibitory Factor (MIF) inhibitors for Autoimmune Diseases Jun 13 Written By Adam Parks Read the Press Release + Adam Parks https://apollocreativeco.com
2012.06.13. Innovimmune awarded NIH NIAID SBIR $0.6 Million grant for the development of its oral NCE INV-88 Macrophage Migration Inhibitory Factor (MIF) inhibitors for Autoimmune Diseases Jun 13 Written By Adam Parks Read the Press Release + Adam Parks https://apollocreativeco.com
